seed
Stage
1
Investors
About
Sigilla Medical develops implant-free cardiac radiofrequency devices for closing intracardiac defects that increase stroke risk. Their minimally invasive system uses controlled radiofrequency energy to seal defects without leaving permanent implants.
Explore Sigilla Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.